Earlier this year, we reported that breast cancer, colorectal cancer, and kidney cancer are all on the rise in the U.S. There ...

Objectives Endometrial cancer (EC) incidence has been rising globally, while mortality has remained stable, particularly in Nordic countries. This study aimed to explore the role of transvaginal ...

Endometrial thickness is measured with a transvaginal ultrasound. You might receive an ultrasound to screen for cancer if you experience bleeding, but the American College of Obstetricians and ...

Key takeaways: Both incidence and mortality rates for uterine cancer are expected to increase through 2050. Black women will experience disproportionate increases compared with white women.

Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, according to early trial findings.

Background: Endometrial cancer, the most prevalent gynecological malignancy, presents a significant public health concern, with disparities in incidence, treatment, and survival outcomes reflecting ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endometrial cancer. The biotech reported a 50% unconfirmed response rate, beating the expectations of William Blair ...

MINNEAPOLIS — Women with vs. without PCOS had a significantly increased risk for endometrial cancer, confirming findings from previous research, according to data presented at the ACOG ...

State Sen. Barbara Favola, D-Arlington, announced Monday that she has been diagnosed with uterine cancer and underwent a hysterectomy on Friday. “The operation was successful and my care team at ...

Diagnosing Endometrial Cancer-Related Bleeding—Via Virtual Visits? —Research results published in the American Journal of Obstetrics and Gynecology suggest that virtual care visits can be ...

Acrivon Therapeutics reported positive interim data for ACR-368 in endometrial cancer and appointed Dr. Mansoor Raza Mirza as CMO.

A major international study, PORTEC-4a, provides the strongest evidence yet that molecular profiling can safely reduce radiotherapy for women with early stage endometrial cancer while identifying ...